Related Experiment Videos
Interstitial lung disease
1Department of Pediatrics, University of Ottawa, Canada.
Insights
Pediatric interstitial lung disease (ILD) has unclear causes and development. Diagnosis involves imaging and lung biopsy, with corticosteroids as the primary treatment, but more research is needed.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Histopathology
Background:
- Interstitial lung disease (ILD) in children presents diagnostic and etiological challenges.
- Current understanding often extrapolates from adult studies, questioning pediatric relevance.
- Liebow's histologic classification is widely adopted for categorizing pediatric ILD.
Purpose of the Study:
- To review the current understanding of pediatric interstitial lung disease.
- To highlight diagnostic modalities and treatment strategies.
- To emphasize the need for further research.
Main Methods:
- Review of existing literature on pediatric ILD.
- Discussion of clinical manifestations, diagnostic tools (imaging, spirometry, biopsy), and treatment.
- Analysis of current classification systems.
Main Results:
- Clinical presentation is variable, ranging from asymptomatic to specific signs like tachypnea.
- Chest X-rays and CT scans aid in diagnosis and staging.
- Lung biopsy remains the gold standard for diagnosis, and corticosteroids are the primary treatment.
Conclusions:
- Pediatric ILD is complex with multifactorial etiology.
- Further multi-center prospective studies are essential for better understanding and management.
- Current diagnostic and treatment approaches require continued investigation.
Abstract:
Interstitial lung disease in children is a complex group of disorders whose etiology and pathogenesis is not entirely clear. Although the basic pathogenesis has been extrapolated from adult studies, its relevance in the pediatric population can be questioned. Several classifications of this condition have been put forward but Liebow's histologic classification is well accepted. Clinical manifestations are non-specific and can vary from no symptoms and a positive chest X-ray to more characteristic signs and symptoms. The triad of tachypnea, intercostal retractions and dry crackles is characteristic. Chest roentgenograms are a useful diagnostic tool and CT scans help to stage disease severity. Spirometry classically shows a restrictive pattern. Lung biopsy is the gold standard for establishing a diagnosis. Corticosteroids are the cornerstone of treatment in this condition. Thus, in view of the multifactorial nature of this disease, more extensive multi-centre prospective studies are required in order to better understand this rather complex group of disorders.